FdaApplication
NDA 218275
Identifiers
- fda_app_no: NDA218275
Properties
| Property | Value |
|---|---|
| applicant_name | ISTX LLC |
| application_type | NDA |
| approval_date | 2024-04-03 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZEVTERA | CEFTOBIPROLE MEDOCARIL SODIUM | 667MG/VIAL | POWDER;INTRAVENOUS |
1 product